Trial Profile
Efficacy of omalizumab in patients with severe allergic asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 14 Jan 2016 New trial record